Koch, Nathan ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Bourcy, Quentin ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM) ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Jennotte, Olivier ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Chiap, Patrice ; Université de Liège - ULiège > Département de pharmacie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de toxicologie clinique, médicolégale, environnementale et en entreprise
Lechanteur, Anna ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Cardot, Jean-Michel; SAS Borvo
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Language :
French
Title :
Selection of In Vivo Relevant Dissolution Test Parameters for the Development of Cannabidiol Formulations with Enhanced Oral Bioavailability
Barrett J.A. Yang W. Skolnik S.M. Belliveau L.M. Patros K.M. Discovery Solubility Measurement and Assessment of Small Molecules with Drug Development in Mind Drug Discov. Today 2022 27 1315 1325 10.1016/j.drudis.2022.01.017 35114363
Anane-Adjei A.B. Jacobs E. Nash S.C. Askin S. Soundararajan R. Kyobula M. Booth J. Campbell A. Amorphous Solid Dispersions: Utilization and Challenges in Preclinical Drug Development within AstraZeneca Int. J. Pharm. 2022 614 121387 10.1016/j.ijpharm.2021.121387 34933082
Salunke S. O’Brien F. Cheng Thiam Tan D. Harris D. Math M.C. Ariën T. Klein S. Timpe C. Oral Drug Delivery Strategies for Development of Poorly Water Soluble Drugs in Paediatric Patient Population Adv. Drug Deliv. Rev. 2022 190 114507 10.1016/j.addr.2022.114507 36049580
Ji L. Feng W. Chen H. Chu Y.J. Wong A. Zhu Y. Sinatra G. Bramante F. Carrière F. Stocks M.J. et al. Rapeseed Oleosomes Facilitate Intestinal Lymphatic Delivery and Oral Bioavailability of Cannabidiol Int. J. Pharm. 2025 668 124947 10.1016/j.ijpharm.2024.124947
Izgelov D. Davidson E. Barasch D. Regev A. Domb A.J. Hoffman A. Pharmacokinetic Investigation of Synthetic Cannabidiol Oral Formulations in Healthy Volunteers Eur. J. Pharm. Biopharm. 2020 154 108 115 10.1016/j.ejpb.2020.06.021
Devinsky O. Kraft K. Rusch L. Fein M. Leone-Bay A. Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study J. Pharm. Sci. 2021 110 3946 3952 10.1016/j.xphs.2021.08.012
Atalay S. Jarocka-Karpowicz I. Skrzydlewksa E. Antioxidative and Anti-Inflammatory Properties of Cannabidiol Antioxidants 2020 9 21 10.3390/antiox9010021
Kirkland A.E. Fadus M.C. Gruber S.A. Gray K.M. Wilens T.E. Squeglia L.M. A Scoping Review of the Use of Cannabidiol in Psychiatric Disorders Psychiatry Res. 2022 308 114347 10.1016/j.psychres.2021.114347
Devinsky O. Cilio M.R. Cross H. Fernandez-Ruiz J. French J. Hill C. Katz R. Di Marzo V. Jutras-Aswad D. Notcutt W.G. et al. Cannabidiol: Pharmacology and Potential Therapeutic Role in Epilepsy and Other Neuropsychiatric Disorders Epilepsia 2014 55 791 802 10.1111/epi.12631
Koch N. Jennotte O. Gasparrini Y. Vandenbroucke F. Lechanteur A. Evrard B. Cannabidiol Aqueous Solubility Enhancement: Comparison of Three Amorphous Formulations Strategies Using Different Type of Polymers Int. J. Pharm. 2020 589 119812 10.1016/j.ijpharm.2020.119812
Koch N. Jennotte O. Bourcy Q. Lechanteur A. Deville M. Charlier C. Chiap P. Cardot J.M. Evrard B. Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase the In Vivo Cannabidiol Bioavailability in Piglets Int. J. Pharm. 2024 657 124173 10.1016/j.ijpharm.2024.124173 38685441
Hossain K.R. Alghalayini A. Valenzuela S.M. Current Challenges and Opportunities for Improved Cannabidiol Solubility Int. J. Mol. Sci. 2023 24 14514 10.3390/ijms241914514 37833962
Knaub K. Sartorius T. Dharsono T. Wacker R. Wilhelm M. Schön C. A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects Molecules 2019 24 2967 10.3390/molecules24162967 31426272
Pestieau A. Evrard B. In Vitro Biphasic Dissolution Tests and Their Suitability for Establishing In Vitro-In Vivo Correlations: A Historical Review Eur. J. Pharm. Sci. 2017 102 203 219 10.1016/j.ejps.2017.03.019
Patel S.K. Greene A.C. Desai S.M. Rothstein S. Basha I.T. MacPherson J.S. Wang Y. Zou Y. Shehabeldin M. Sfeir C.S. et al. Biorelevant and Screening Dissolution Methods for Minocycline Hydrochloride Microspheres Intended for Periodontal Administration Int. J. Pharm. 2021 596 120261 10.1016/j.ijpharm.2021.120261
Koch N. Jennotte O. Toussaint C. Lechanteur A. Evrard B. Production Challenges of Tablets Containing Lipid Excipients: Case Study Using Cannabidiol as Drug Model Int. J. Pharm. 2023 633 122639 10.1016/j.ijpharm.2023.122639
Bake E. Comer J.E.A. Takács-Novák K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound J. Pharm. Bio Anal. 2008 46 335 341 10.1016/j.jpba.2007.10.030
Koch N. Jennotte O. Lechanteur A. Deville M. Charlier C. Cardot J. Chiap P. Evrard B. An Intravenous Pharmacokinetic Study of Cannabidiol Solutions in Piglets through the Application of a Validated UPLC—MS/MS Method for the Simultaneous Quantification of CBD and Its Carboxylated Metabolite in Plasma Pharmaceutics 2024 16 140 10.3390/pharmaceutics16010140
Cardot J.M. Lukas J.C. Muniz P. Time Scaling for In Vitro-In Vivo Correlation: The Inverse Release Function (IRF) Approach AAPS J. 2018 20 95 10.1208/s12248-018-0250-5
Mellaerts R. Mols R. Jammaer J.A.G. Aerts C.A. Annaert P. Van Humbeeck J. Van den Mooter G. Augustijns P. Martens J.A. Increasing the Oral Bioavailability of the Poorly Water Soluble Drug Itraconazole with Ordered Mesoporous Silica Eur. J. Pharm. Biopharm. 2008 69 223 230 10.1016/j.ejpb.2007.11.006
Sitovs A. Logviss K. Lauberte L. Mohylyuk V. Oral Delivery of Cannabidiol: Revealing the Formulation and Absorption Challenges J. Drug Deliv. Sci. Technol. 2024 92 105316 10.1016/j.jddst.2023.105316
Pestieau A. Krier F. Brouwers A. Streel B. Evrard B. Selection of a Discriminant In Vitro Dissolution Test for the Development of Fenofibrate Self-Emulsifying Lipid-based Formulation Eur. J. Pharm. Sci. 2016 92 212 219 10.1016/j.ejps.2016.04.038 27169683
Mármol A.L. Denninger A. Touzet A. Dauer K. Becker T. Pöstges F. Pellequer Y. Lamprecht A. Wagner K.G. The Relevance of Supersaturation and Solubilization in the Gastrointestinal Tract for Oral Bioavailability: An in vitro vs. in vivo approach Int. J. Pharm. 2021 603 120648 10.1016/j.ijpharm.2021.120648
Golombek P. Müller M. Barthlott I. Sproll C. Lachenmeier D.W. Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature Toxics 2020 8 41 10.3390/toxics8020041
Xie X. Cardot J.M. Garrait G. Thery V. El-Hajji M. Beyssac E. Micelle Dynamic Simulation and Physicochemical Characterization of Biorelevant Media to Reflect Gastrointestinal Environment in Fasted and Fed States Eur. J. Pharm. Biopharm. 2014 88 565 573 10.1016/j.ejpb.2014.05.020
